Price$80.84-1.48 (-1.80%)
02:30 PM07:45 PM
News · 26 weeks40-82%
2026-04-192026-10-11
Mix1890d
- Insider10(56%)
- SEC Filings3(17%)
- Earnings2(11%)
- Other2(11%)
- Analyst1(6%)
Latest news
25 items- SECSEC Form 8-K filed by LeMaitre Vascular Inc.8-K - LEMAITRE VASCULAR INC (0001158895) (Filer)
- PRLeMaitre Will Announce Third Quarter 2026 Earnings Results on November 4, 2026BURLINGTON, Mass., Oct. 12, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its third quarter 2026 financial results on Wednesday, November 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EST the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment
- INSIDERSEC Form 4 filed by President and Director Roberts David B4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director Pellegrino Joseph P Jr4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director Jasinski Lawrence J4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director O'Connor John James4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director Shadan Martha4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Chairman and CEO Lemaitre George W4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Leblanc Dorian Paul4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Senior V. P., Operations Kamke Trent G4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director Roush John A4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by LeMaitre Vascular Inc.4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- PRLeMaitre to Participate at Upcoming Investor Conferences in SeptemberBURLINGTON, Mass., Aug. 27, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that management will participate in three upcoming investor conferences. Wells Fargo 21st Annual Healthcare Conference Tuesday, September 8, 2026, in BostonDorian LeBlanc, CFO, will participate in a Fireside Chat at 8:45 AM ET Morgan Stanley 24th Annual Global Healthcare Conference Wednesday, September 16, 2026, in New York CityDorian LeBlanc, CFO, will participate in a Fireside Chat at 12:20 PM ET 19th Annual Barrington Research Virtual Fall Investment Conference Tuesday, September 22, 2026Dorian LeBlanc, CFO, time to be announced About LeMaitre LeMaitre is a provider of devices
- PRLeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 ConferenceBURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. About LeMaitre LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com. Contact: Sandra MillarLeMaitre Vascular, In
- ANALYSTLemaitre Vascular downgraded by Barrington ResearchBarrington Research downgraded Lemaitre Vascular from Outperform to Mkt Perform
- SECSEC Form 10-Q filed by LeMaitre Vascular Inc.10-Q - LEMAITRE VASCULAR INC (0001158895) (Filer)
- SECLeMaitre Vascular Inc. filed SEC Form 8-K: Results of Operations and Financial Condition8-K - LEMAITRE VASCULAR INC (0001158895) (Filer)
- PRLeMaitre Q2 2026 Financial ResultsBURLINGTON, Mass., Aug. 04, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT), a provider of vascular devices, implants, and services, today reported Q2 2026 results, announced a quarterly dividend of $0.25/share, and provided guidance. Q2 2026: Sales $70.4mm, +10% (+10% organic) vs. Q2 2025Gross margin 72.1% (+210 bps)Op. income $20.4mm (+26%) Op. margin 29%EPS $0.74 (+23%)Cash up $9.0mm sequentially to $376.2mm Artegraft sales increased 34% in the quarter. Grafts (+23%), carotid shunts (+18%), and patches (+4%) each posted records, as did EMEA (+18%), APAC (+18%) and the Americas (+5%). Catheters were down 11% in the quarter due to recall-driven overstocking in Q2 2025. Q
- PRLeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026BURLINGTON, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (NASDAQ:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook. Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com. About LeMaitre LeMaitre is a provider of devices, implants, and services for the treatment of
- INSIDERSEC Form 4 filed by Director Jasinski Lawrence J4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director O'Connor John James4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director Roush John A4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director Shadan Martha4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Director Pellegrino Joseph P Jr4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
- INSIDERSEC Form 4 filed by Chief Financial Officer Leblanc Dorian Paul4 - LEMAITRE VASCULAR INC (0001158895) (Issuer)
LMAT FAQ
8 questionsWhat does LeMaitre Vascular Inc. do?
LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. It offers angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries or veins; occlusion catheters that temporarily occlude the blood flow; perfusion catheters to perfuse the blood and other fluids into the vasculature; and thrombectomy catheters, which features a silicone balloon for removing thrombi in the venous system. The company also provides carotid...Where does LMAT stock trade?
LeMaitre Vascular Inc. (LMAT) is listed on NASDAQ.What sector and industry is LMAT in?
LeMaitre Vascular Inc. operates in the Health Care sector, Medical/Dental Instruments industry.When did LeMaitre Vascular Inc. go public?
LeMaitre Vascular Inc. (LMAT) completed its IPO in 2006.Does LMAT pay a dividend?
LMAT's most recent ex-dividend date was 2026-08-20 with a cash dividend of $0.25 per share. No future ex-date is on file yet.What are analysts saying about LMAT?
LeMaitre Vascular Inc. has had 8 recent analyst actions on file. The most recent action was from Barrington Research: Mkt Perform on 2026-08-05.What companies are similar to LMAT?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare LMAT side-by-side with any of them on Quantisnow.How can I track LMAT on Quantisnow?
Quantisnow aggregates LeMaitre Vascular Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow LMAT to receive live email and push alerts on every new disclosure.